Circulating Protein Signatures and Causal Candidates for Type 2 Diabetes.

With consideration of a second validation tier as being nominally significant and directionally consistent in the other cohort, these proportions amounted to 57% and 88% for AGES-Reykjavik and QMDiab, respectively ( Fig. 1E ).

also in 7,732 other papers